Palleon Pharmaceuticals
Founded
2016
2016
Patents
3
3
Clinical Trials
1
1
Publications
1
1
Technologies
Pharmaceutical and Drug DiscoveryPalleon Pharmaceuticals develops drugs that target sugar-sensing molecules on the surfaces of cells. It has integrated technologies and insights from world-renowned scientific leaders in glycoscience and human immunology to create the first Glycoimmune Checkpoint Inhibitors to treat cancer patients.